Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Rhoda Masonga"'
Autor:
Nginache Nampota-Nkomba, Osward M. Nyirenda, Victoria Mapemba, Rhoda Masonga, Priyanka D. Patel, Theresa Misiri, Felistas Mwakiseghile, Richard Wachepa, John M. Ndaferankhande, Bright Lipenga, Pratiksha Patel, Happy Banda, Jennifer Oshinsky, Marcela F. Pasetti, Robert S. Heyderman, Leslie P. Jamka, Divya Hosangadi, Shrimati Datta, Melita A. Gordon, Kathleen M. Neuzil, Matthew B. Laurens
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 20, Iss 1 (2024)
Vaccine safety and immunogenicity data in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children are important for decision-making in HIV and typhoid co-endemic countries. In an open-label study, we recruited Malawian HEU and HIV unexpo
Externí odkaz:
https://doaj.org/article/f07e042e084547c98e965b494eb39f5a
Autor:
Miriam K Laufer, Phillip C Thesing, Fraction K Dzinjalamala, Osward M Nyirenda, Rhoda Masonga, Matthew B Laurens, Abbie Stokes-Riner, Terrie E Taylor, Christopher V Plowe
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e42284 (2012)
The predominance of chloroquine-susceptible falciparum malaria in Malawi more than a decade after chloroquine's withdrawal permits contemplation of re-introducing chloroquine for targeted uses. We aimed to compare the ability of different partner dru
Externí odkaz:
https://doaj.org/article/643831e292fb432594186a5d25d1e77b
Autor:
Priscilla Mvula, Lufina Tsirizani, Jaya Goswami, Rhoda Masonga, Atis Muehlenbachs, Jessie K. Kennedy, Titus H. Divala, Maxwell Kanjala, Osward M. Nyirenda, Blair J. Wylie, Lughano Ndovie, Sarah Boudova, Miriam K. Laufer, Yamikani Mbilizi, Patricia Mawindo, Randy G. Mungwira, Gail E Potter, Masiye John Ndaferankhande, Francis Muwalo, Tamiwe Tomoka
Publikováno v:
The Lancet Infectious Diseases. 18:1097-1107
BACKGROUND: Sulfadoxine-pyrimethamine resistance threatens efficacy of intermittent preventive treatment of malaria during pregnancy, and alternative regimens need to be identified. With the return of chloroquine efficacy in southern Africa, we postu
Autor:
Shannon L. Takala, Fraction K. Dzinjalamala, Nicole D. Eddington, Phillip C. Thesing, Miriam K. Laufer, Christopher V. Plowe, Rhoda Masonga, Terrie E. Taylor
Publikováno v:
New England Journal of Medicine. 355:1959-1966
BACKGROUND In 1993, Malawi became the first country in Africa to replace chloroquine with the combination of sulfadoxine and pyrimethamine for the treatment of malaria. At that time, the clinical efficacy of chloroquine was less than 50%. The molecul